Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Pipettes Offer Quality Assurance for Endotoxin-Sensitive Applications

By LabMedica International staff writers
Posted on 11 May 2010
A range of serological pipettes is now certified nonpyrogenic to 0.01 ELISA Units (EU)/mL, significantly lower than the market standard of 0.25 EU/mL. More...
The range has also been validated nonhemolytic.

When medical device and pharmaceutical manufacturers perform tests to ensure that their products are free from endotoxins, it is extremely important for them to have confidence in the equipment and materials that they use.

Similarly, when pipetting blood and blood products, it is important that the polymer used does not have a detrimental effect on the sample. Validated nonhemolytic, the serological pipettes protect samples and provide valuable assurance that they will not interfere with the results of hemolysis tests.

Certified nonpyrogenic to a very low level, Sterilin (Bargoed, UK) serological pipettes greatly reduce the risk of endotoxin interference in routine laboratory analyses (such as limulus amebocyte lysate--LAL testing) and, therefore, help to ensure the integrity of results.

Sterilin serological pipettes are manufactured from crystal grade polystyrene to ensure excellent clarity. With crisp black print, ascending and descending graduations, and negative graduations for extra capacity, volumes are extremely easy to read, and accurate to ± 1%.

The comprehensive range includes standard pipette sizes (1 mL, 2 mL, 5 mL, 10 mL, 25 mL, and 50 mL) in addition to "Shortie” pipettes (5 mL and 10 mL), which are ideal for use in laminar flow cabinets. The gamma-irradiated pipettes are individually wrapped in paper peel or plastic film to maintain quality during storage.

Related Links:

Sterilin




Gold Member
Collection and Transport System
PurSafe Plus®
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sperm Quality Analyis Kit
QwikCheck Beads Precision and Linearity Kit
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.